Publications

Relevant publications from our scientists

  • Richard Danger, Ludmilla Le Berre, Marion Cadoux, Clarisse Kerleau, Emmanuelle Papuchon, Pierrick Guérif, Emmanuel Morelon, Olivier Thaunat, Christophe Legendre, Dany Anglicheau, Carmen Lefaucheur, Lionel Couzi, Arnaud Del Bello, Nassim Kamar, Moglie Le Quintrec, Valentin Goutaudier, Karine Renaudin, Magali Giral, Sophie Brouard,
    Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression,
    Kidney International, 2023                                                        https://doi.org/10.1016/j.kint.2023.03.019

  • Danger R, Moiteaux Q, Feseha Y, Geffard E, Ramstein G, Brouard S (2021) FaDA: A web application for regular laboratory data analyses. PLoS ONE 16(12): e0261083. https://doi.org/10.1371/journal.pone.0261083

  • Tissot A, Danger R, Claustre J, Magnan A, Brouard S. Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers. Front Immunol. 2019 Jul 17;10:1681. 2019. Review.

  • Belarif L*, Danger R*, Kermarrec L*, Nerrière-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, Thepenier V, Martin JC, Chang C, Rahman A, Guen NS, Braudeau C, Abidi A, David G, Malard F, Takoudju C, Martinet B, Gérard N, Neveu I, Neunlist M, Coron E, MacDonald TT, Desreumaux P, Mai HL, Le Bas-Bernardet S, Mosnier JF, Merad M, Josien R, Brouard S, Soulillou JP, Blancho G, Bourreille A, Naveilhan P, Vanhove B, Poirier N. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest. 2019 Apr 2;129(5):1910-1925.
  • Danger R*, Royer P-J*, ReboulleauD, Loy J, Tissot A, Lacoste P, Roux A, Reynaud-Gaubert M, Kessler R, Mussot S, Dromer C, Brugière O, Mornex JF, Guillemain R, Dahan M, Knoop C, Botturi K, Pison C, Nicod L, Brouard S, Magnan A *equal contributions. Blood gene expression predicts bronchiolitis obliterans syndrome. Front. Immunol. 2017.
  • Danger R, Chesneau M,  Paul C,  Guérif P, Durand M, Newell K A, Kanaparthi S, Turka L A, Soulillou J-P, Houlgatte R, Giral M, Ramstein G, and Brouard S. ‘A composite score associated with spontaneous operational tolerance in kidney transplant recipients’. Kidney International 2017: 91(6): 1473–1481.
  • Danger R, Sawitzki B, and Brouard S. ‘Immune monitoring in renal transplantation: The search for biomarkers’. Eur. J. Immunol 2016: 46: 2695–2704.
  • Chesneau M, Miche L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud D-A, Soulillou J-P, Magali Giral M, Nicolas Degauque N, Elise Chiffoleau E, and Brouard S. ‘Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties ‘. J Am Soc Nephrol 2015: 26: 2588–2598.
  • Baron D, Ramstein G, Chesneau M, Echasseriau Y, Pallier A, Paul C, Degauque N, Hernandez-Fuentes MP, Sanchez-Fueyo A, Newell KA, Giral M, Soulillou J-P, Houlgatte R, and Brouard S. ‘A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft’. Kidney International 2015: 87, 984–995.
  • Chesneau M, Pallier A, Braza F, Lacombe G, Le Gallou S,  Baron D, Giral M, Danger R, Guerif P, Aubert-Wastiaux H, Néel A, Michel L, Laplaud D-A, Degauque N, Soulillou J-P, Tarte K, and Brouard S. ‘Unique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients’.  Am J Transplant 2013: 14: 144–155.
  • Pallier A, Hillion S, Danger R, Magali Giral M, Racape M, Degauque N, Dugast E, Ashton-Chess J, Pettre S, Lozano JJ, Bataille R, Devys A, Cesbron-Gautier A, Braudeau C, Larrose C, Soulillou J-Pand Brouard S. ‘Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype ‘. Kidney International 2010: 78, 503–513.
  • Brouard S, Mansfield E, Braud C, Li L, Giral M,  Hsieh S-C, Baeten D, Zhang M, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S , Ruizh C, Salvatierra O, Soulillou J-P, and Sarwal M. ‘Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance’. PNAS 2007: vol. 104, no. 39, 15448–15453.

Other publications of interest

  • Tharushi de Silva, Joanne Voisey, Peter Hopkins, Simon Apte, Daniel Chambers & Brendan O’Sullivan ‘Markers of rejection of a lung allograft: state of the art’, Biomark.Med. 2022, 10.2217/bmm-2021-1013

  • Puttarajappa C.M, Mehta R.B, Roberts M.S, Smith K.J, Hariharan S. ‘Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers’. Am J Transplant 2021: 21:186–197.
  • Thaunat O. ‘Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression’. Kidney International 2015: 88, 1226–1228.
  • Lamb K.E, Lodhi S and Meier-Kriesche H.-U. ‘Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal’. Am J Transplant 2011: 11: 450–462.
  • Nankivell B.J, Borrows R.J, Fung C.L.-S, O’Connell P.J, Allen R.D.M, and Chapman J.R. ‘Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation’. Transplantation 2004: 78: 242–249.
  • Miller L.W. ‘Cardiovalscular toxicities of immunosupressive agents’. Am J Transplant 2002: 2: 807-818.
  • Furness P.N, Taub N. ‘International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project’. Kidney International 2001: 60:1998–2012.